Axitinib

COMPOSITION:

Each film-coated tablet contains Axitinib……5mg.

INDICATION:

LuciAxi is a kinase inhibitor indicated for the treatment of advanced renal cell carcinoma after failure of one prior systemic therapy.

DOSAGE AND USE:

• The starting dose is 5 mg orally twice daily. Dose adjustments can be made based on

individual safety and tolerability.

• Administer LuciAxi dose approximately 12 hours apart with or without food.

STORAGE:

In a dry place and store at 20°C to 25°C.

MANUFACTURED AND MARKETED BY:

LUCIUS PHARMACEUTICALS(LAO) CO., LTD

No.26, Thongmang village, Xaythany district, Vientiane Capital, Laos

WARNING:

Keep medicine out of reach of Children. Do not administer LuciAxi during Pregnancy and Lactation.